This review, conducted by Innovation Lab for Vaccine Delivery Research (VaxLab) from Duke Kunshan University, was published in Vaccine. The study systematically compares the status of new vaccine introduction within national immunization programs across 13 countries in Southeast and South Asia, with a particular focus on differences associated with Gavi funding eligibility. The findings show that countries eligible for Gavi’s middle-income country (MIC) support approach lag behind in introducing key vaccines such as pneumococcal conjugate vaccine (PCV), human papillomavirus (HPV) vaccine, and rotavirus vaccine. Major barriers include underdeveloped evidence-based decision-making processes, limited domestic financing, high vaccine prices, and gaps in immunization system readiness. This article highlights the need to strengthen governance and sustainable financing mechanisms, optimize resource use, and leverage targeted technical support from global partners to accelerate equitable access to life-saving vaccines and advance the Immunization Agenda 2030.
HPV Vaccination Policies and Implementation for Adolescents in Low- and Middle-Income Countries: A Scoping Review
This scoping review, published in The Lancet Regional Health – Western Pacific by Prof. Qing LIU and team from Chongqing Medical University, examined adolescent HPV vaccination policies and implementation experiences across 84 low- and middle-income countries (LMICs) that had incorporated HPV vaccination into their national immunization programs, and synthesized implementation evidence available through July 2025, with a focus on adolescents aged 9–14 years. The review found substantial policy convergence in target age groups, school-based delivery, and free vaccination, while important differences remained in gender eligibility, vaccine type, and financing mechanisms.Vaccination schedules have also become progressively simpler, with nearly half of LMICs adopting single-dose regimens. Despite continued policy progress, substantial coverage gaps remain. Among countries reporting complete-dose coverage in 2024, only 9.8% achieved the WHO target of 90% of girls being fully vaccinated by age 15.Trend analyses suggested that school-based programs generally demonstrated more stable coverage over time. The study suggests that school-based vaccination, complemented by mixed delivery strategies and simplified single-dose schedules, may provide a promising pathway to expand HPV vaccine coverage and advance cervical cancer elimination in resource-limited settings.